Welcome to Revolution Medicines

Our RAS(ON) inhibitor clinical trials are intended to evaluate safety and efficacy in patients with RAS-mutant cancers with unmet medical need

To get started, please let us know if you are an interested healthcare professional

Yes, I am a Healthcare Professional

No, I am not a Healthcare Professional

Loading...

Patient Trial Finder

Are you 18 years or older?

yes

no

NCT06625320, NCT06881784, NCT06162221, NCT06040541, NCT06445062, NCT06128551, NCT05462717, NCT05379985,

Patient Trial Finder

Each clinical trial has specific criteria required for enrollment. Based on your answers to the previous question(s), unfortunately you do not qualify to participate in one of our clinical trials at this time.

restart?

NCT06625320, NCT06881784, NCT06162221, NCT06040541, NCT06445062, NCT06128551, NCT05462717, NCT05379985,

Patient Trial Finder

Which type of cancer are you interested in/have been diagnosed with?

Pancreatic ductal adenocarcinoma (PDAC)

Non-small cell lung cancer (NSCLC)

Advanced solid tumors including PDAC, NSCLC, and colorectal cancer (CRC)

NCT06625320, NCT06881784, NCT06162221, NCT06040541, NCT06445062, NCT06128551, NCT05462717, NCT05379985,

Patient Trial Finder

Are you interested in/have a documented RAS mutation status?

yes

no

NCT06625320, NCT06881784, NCT06162221, NCT06040541, NCT06445062, NCT06128551, NCT05462717, NCT05379985,

Patient Trial Finder

Have you been recommended any of the following interventions?

Daraxonrasib (RMC‑6236)

Elironrasib (RMC-6291)

Zoldonrasib (RMC-9805)

NCT06625320, NCT06881784, NCT06162221, NCT06040541, NCT06445062, NCT06128551, NCT05462717, NCT05379985,

Patient Trial Finder

Please enter your location to find clinical trials that are recruiting in your chosen country

NCT06625320, NCT06881784, NCT06162221, NCT06040541, NCT06445062, NCT06128551, NCT05462717, NCT05379985,

Patient Trial Finder

The results!

NCT06625320, NCT06881784, NCT06162221, NCT06040541, NCT06445062, NCT06128551, NCT05462717, NCT05379985,